An observational study in Coronary Artery Stenosis, Coronary Artery Disease and Blood Pressure, sponsored by Hanyang University Seoul Hospital. Recruiting at 3 sites in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2023-07-07.
Sponsored by Hanyang University Seoul Hospital · Observational
Among 31 studies in Coronary Stenosis with a site in Korea, Republic of — 9 open to participants now, 10 under way, none of them phase 3. Coronary Stenosis · Korea, Republic of.
Among the 31 studies in Coronary Stenosis with a site in Korea, Republic of, this one has the largest planned enrollment of the 16 observational ones that give a count, is the only one that started in 2012, is one of 16 observational ones, and was the 26th registered.
326 studies on the registry are indexed under Coronary Stenosis; 57 are open to participants now.
Browse Coronary Stenosis studies →9 of the 31 studies in Coronary Stenosis with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Samsung Medical Center · Sites in Korea, Republic of
Samsung Medical Center · Sites in Korea, Republic of
Seung-Jung Park · Sites in Korea, Republic of
Duk-Woo Park, MD · Sites in Korea, Republic of, United States, Australia and 11 more countries
Seung-Jung Park · Sites in Korea, Republic of
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 40 Coronary Stenosis studies recruiting now, 33 (83%) set no upper age limit and 3 (8%) stop at 75 or younger; 4 take children under 18; 2 take healthy volunteers.
This study: 19 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2012.
This study's planned enrollment of 5,000 is above the median of 200 across 125 observational studies indexed under Coronary Stenosis.
Median enrollment 1,200 across the 15 interventional studies, 1,000 across the 16 observational. Of the 15 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 31 have an industry lead sponsor. The 10 most frequent:
Hanyang University Seoul Hospital is the lead sponsor of 26 studies on the registry; 5 are open to participants now.
Hanyang University Seoul Hospital has 1 study filed under Coronary Stenosis — fewer than ten, so there is no comparison to draw.
3 of the studies in Coronary Stenosis with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02792075Seung-Jung ParkPrognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study | 2026-12 |
| NCT03412435Seung-Jung ParkAsan Medical Center Myocardial Infarction Registry | 2026-12-31 |
| NCT05846893B. Braun Medical Industries Sdn. Bhd.Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease | 2027-05 |
Among the 31 studies in Coronary Stenosis with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University Seoul Hospitals and Hanyang University Guri Hospitals were enrolled in this registry.
The aim of this registry is to examine the long-term clinical outcomes and identify predictors of adverse outcomes following percutaneous coronary intervention conducted at academic hospitals.
In the HYUMC registry, the researchers have gathered and assessed various demographic, laboratory, echocardiographic, and angiographic measurements (both on-admission and during follow-up), as well as conducted questionnaires among patients who underwent percutaneous coronary intervention. The primary focus of this registry is to examine the effects of these parameters on long-term clinical outcomes.
Consecutive patients with CAD
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea.
Exclusion Criteria:
patients with CAD undergoing PCI with second generation DES
Device: percutaneous coronary intervention
patients with CAD undergoing PCI with second generation DES
MACCE (major adverse cardiac and cerebrovascular event)
the composite of all-cause death, myocardial infarction, stroke, or any revascularization
Time frame: 10-year
All-cause death
death from any cause
Time frame: 10-year
Myocardial infarction,
presence of clinical symptoms with the presence of electrocardiographic changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormalities, in conjunction with elevated levels of cardiac biomarker above the 99th percentile upper reference limit
Time frame: 10-year
Stroke
neurological deficit resulting from acute focal damage to the central nervous system due to a vascular cause, requiring hospitalization, and confirmed by a neurologist through imaging findings
Time frame: 10-year
Any revascularization
PCI or coronary artery bypass surgery on either target or nontarget vessels
Time frame: 10-year
Plan to share: Undecided — The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
No publications or documents are linked to this record.
Started Jan 2012 (actual). Primary completion is estimated for Dec 2025, 167 months after the start.
Of 58 observational studies under Coronary Stenosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 143. This study's planned 167 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hanyang University Seoul Hospital